
Neumentum, Inc.: A biotech firm specializing in non-opioid analgesic and neurology pharmaceuticals.
Neumentum, Inc. was founded with the mission to revolutionize pain management by developing non-opioid analgesic and neurology specialty pharmaceuticals. The company aims to provide effective and safe alternatives to opioid treatments, addressing the significant risks of abuse, misuse, and life-threatening side effects associated with opioids. Neumentum focuses on creating and commercializing innovative pain management solutions that offer better options for patients suffering from chronic and acute pain.
Notable figures affiliated with Neumentum include experienced professionals from the pharmaceutical and biotechnology sectors. The company has attracted investment from key players in the healthcare industry, underscoring its potential impact. Neumentum's achievements include advancing its product pipeline and gaining recognition for its commitment to addressing the opioid crisis. By offering safer pain management alternatives, Neumentum is poised to make a significant impact on public health and improve the quality of life for patients.
Neumentum's most recent funding round was for $16.6M (USD) in October 2021.
As of Oct 20, 2021, Neumentum has disclosed funding of $34.7M (USD).

Akelos
akelosinc.com

Concentric Analgesics

Neurocarrus
neurocarrus.com

Vapogenix
vapogenix.com

Amalgent Therapeutics
amalgent.com

Tremeau Pharmaceuticals

Neuraly
neuralymed.com

Neuropathix
neuropathix.com

Neuros Medical
neurosmedical.com

NeurAegis
neuraegis.com

Nocion Therapeutics
nociontx.com
Nerium Biotechnology
nbiresearch.com

Neurelis
neurelis.com

Nutra Pharma
nutrapharma.com

NeuraLace Medical
NeurOp
Neumedics
neumedics.com

Neurovia